WHO may give approval to COVAXIN this week

New Delhi, 13/9: Bharat Biotech’s anti-coronavirus vaccine Covaxin  is expected to get the approval of the World Health Organization (WHO) this week, sources said on Monday. In fact, at present the vaccine is not part of the WHO emergency use list and for this reason the COVAXIN  vaccine used in India has not been recognized by many countries.

The biggest loss of this is being suffered by those who want to travel to those countries due to their work or any other reason, where their entry is banned due to non-approval of the Covaccine by the WHO. According to WHO guidelines, Emergency Use Listing (EUL) is the process by which new or unlicensed products are approved for use in times of public health crisis.

Bharat Biotech had submitted the documents to WHO on 9 July, however all the documents required for inclusion of the vaccine in the emergency use list were submitted by Bharat Biotech to the WHO by 9 July and the review process by the agency had also started. In such a situation, it is expected that soon the Covaccine will get approval from WHO. Currently, WHO has approved vaccines from Pfizer-BioNtech, AstraZeneca-SK Bio-Serum Institute of India, AstraZeneca EU, Janssen, Moderna and Sinopharm for emergency use.

Comments are closed.